Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm
NCT00234507 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2019-07-29
Summary
The purpose of this study is to compare the effectiveness of 3 doses of Dysport® with placebo by assessing functional disability in blepharospasm.
Conditions
- Blepharospasm
Interventions
- BIOLOGICAL
-
Botulinum toxin type A
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Ipsen Study Director · Ipsen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Primary Completion
- 2004-05-25
- Completion
- 2004-05-25
Countries
- United States
Study Locations
More Related Trials
-
Dysport® Adult Lower Limb Spasticity Study
NCT01249404 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Dysport® and Botox® in the Treatment of Cervical Dystonia
NCT00950664 ·Status: COMPLETED ·Phase: PHASE4
-
Post Marketing Surveillance Study of Dysport
NCT00210431 ·Status: COMPLETED
-
Dysport® Adult Upper Limb Spasticity Extension Study
NCT01313312 ·Status: COMPLETED ·Phase: PHASE3
-
Dysport for the Treatment of OMD
NCT01921270 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dysport Dose-Ranging Treatment of Platysmal Bands
NCT04886167 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Pilot Study for Use of Dysport in Treatment of Vocal Tics in Patients With Tourette's Syndrome
NCT02187679 ·Status: UNKNOWN ·Phase: NA
-
Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children
NCT02106351 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)
NCT00247559 ·Status: COMPLETED ·Phase: PHASE2
-
Dysport® Pediatric Lower Limb Spasticity Study
NCT01249417 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Two Commercial Preparations of Botulinum Toxin Type A
NCT00959907 ·Status: COMPLETED ·Phase: PHASE4
-
A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor
NCT03136341 ·Status: RECRUITING ·Phase: PHASE4
-
Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
NCT00288509 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
NCT04936542 ·Status: COMPLETED ·Phase: PHASE4
-
Dysport® Adult Lower Limb Spasticity Follow-on Study
NCT01251367 ·Status: COMPLETED ·Phase: PHASE3
-
Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis
NCT01357980 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
NCT00578097 ·Status: TERMINATED ·Phase: PHASE2
-
Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity
NCT00234546 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients
NCT04589364 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain
NCT02221648 ·Status: TERMINATED ·Phase: PHASE2
-
Effectiveness and Safety of Dysport® (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity
NCT03017729 ·Status: COMPLETED
-
Dysport in the Treatment of Glabellar Lines in Chinese Subjects
NCT02450526 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm
NCT01259557 ·Status: COMPLETED ·Phase: PHASE4
-
Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm
NCT03508882 ·Status: COMPLETED ·Phase: PHASE4
-
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
NCT00764634 ·Status: COMPLETED ·Phase: PHASE2